With around 65 million patients worldwide, chronic obstructive pulmonary disease (COPD) is anything but uncommon. In fact, it’s one of the most prevalent lung conditions in the world behind asthma. However, despite these statistics, COPD is labeled an “invisible illness.” Many people suffer with this condition in silence, and society as a whole tends to stigmatize it by misunderstanding what its causes are and what life is like with this condition.

Chronic obstructive pulmonary disease (COPD) is one of the diseases with the greatest financial burdens worldwide and within the United States. Studies have shown that the average annual COPD-related expenditure is around $4,147. And while 51% of these costs are covered by Medicare according to the Centers for Disease Control and Prevention (CDC), that still leaves roughly $2,000 a year that COPD patients need to spend out-of-pocket. Combine this with the cost of aging and limited retirement funds and it’s not hard to see why COPD is such a major financial burden for so many people.

Supplemental oxygen therapy or long term oxygen therapy (LTOT), is an at home therapy process 1.5 million Americans utilize everyday in order to improve their quantity and quality of living with chronic lung diseases.

There are three main types of respiratory disease: airway diseases, lung tissue diseases, and circulatory diseases. The first type, airway diseases, affect the tubes called bronchioles, usually causing them to narrow, swell, or become filled with a slimy substance called mucus. Airway diseases include asthma, a specific type of chronic obstructive pulmonary disease (COPD) called chronic bronchitis, and bronchiectasis, a condition that results from recurrent lung infections.

Nowadays, life is all about choices. We get to choose where we shop, eat, work, and much more. For the most part, this is a positive thing because it allows us the freedom to create a life that’s suited to our wants and needs. Oxygen patients, for example, can benefit from many decades of improvement in oxygen device technology and they have a wider array of options available to them than ever before including oxygen tanks, liquid oxygen tanks, stationary oxygen concentrators, and portable oxygen concentrators.

We are writing this article to answer the million dollar question: Are portable oxygen concentrators worth the upfront costs? 

To clarify, we are a medical equipment company in Denver Colorado, and our specialty is in portable oxygen concentrators (POC). We work closely with these devices everyday along with the folks and families that need them. It is our number one priority to educate, execute, ensure. This means educating everyone that calls, messages, emails, or comments with inquiries about our oxygen devices. Executing the sales process effectively and efficiently, so our customers can get their oxygen device as soon as possible. And lastly ensuring that all of our customers are happy, satisfied, and taking full advantage of their oxygen device.

Whether you have a friend or a loved one with COPD or you have COPD yourself, you can likely attest to the fact that this disease can cause significant problems with mobility. The top causes of mobility issues in COPD patients include poor pulmonary function, leg swelling (peripheral edema), and loss of muscle mass (muscle atrophy). Combined with the effects of aging and other chronic conditions like osteoarthritis, COPD patients can experience a lot of difficulties getting around in their day-to-day life.

When we’re younger, we often take for granted our ability to get around with ease. Whether it’s a trip to the grocery store once a week or a month-long trip across the country, there are very few physical limitations setting us back. But as we get older, tasks that used to be second nature to us now become strenuous exercise. This is further complicated by the fact that older adults are more likely to suffer from chronic conditions like osteoarthritis, heart disease, and chronic obstructive pulmonary disease (COPD), all of which are debilitating.

Chronic obstructive pulmonary disease (COPD) is one of the most substantial health burdens in the world. According to the Centers for Disease Control and Prevention, “chronic lower respiratory disease” (primarily COPD) is fourth on the list of leading causes of death worldwide, behind heart disease, cancer, and unintentional accidents. And despite the fact that fewer people are smoking than ever before, experts are expecting the number of COPD cases to rise within the next 50 years.

Chronic obstructive pulmonary disease (COPD) is one of the leading respiratory diseases in the world in terms of morbidity and mortality. Around 65 million people have it, and many experts are expecting that number to grow over the next 50 years. One thing that’s unique about COPD is the fact that it develops very slowly over the course of many years. Because of this, many COPD patients are susceptible to complications that are as bad, or even worse than their underlying condition.